Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
Iclepertin for Schizophrenia
Recruiting1 awardPhase 3
Saint Louis, Missouri
This trial is testing whether a medicine called BI 425809 can improve learning and memory in people with schizophrenia. Schizophrenia affects the way a person thinks and their mental functioning. The trial involves taking BI 425809 or a placebo once a day for 26 weeks, in addition to normal medication for schizophrenia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.